| Date Filed | Type | Description |
| 08/18/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 31,444 shares
@ $0
Paid exercise price by delivering 13,192 shares
@ $7.94, valued at
$104.7k
Granted 19,223 shares
@ $0
Paid exercise price by delivering 8,065 shares
@ $8.18, valued at
$66k
|
|
| 08/15/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,045 shares
@ $0
Sold 1,760 shares
@ $7.89, valued at
$13.9k
|
|
| 08/14/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,451 shares
@ $0
Sold 1,850 shares
@ $8.1, valued at
$15k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,855 shares
@ $0
Sold 2,106 shares
@ $8.08, valued at
$17k
|
|
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 5,259 shares
@ $0
Sold 2,317 shares
@ $8.32, valued at
$19.3k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 113,538 shares
@ $0
Paid exercise price by delivering 47,630 shares
@ $7.93, valued at
$377.7k
|
|
| 05/24/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 3,877 shares
@ $8, valued at
$31k
Sold 50,000 shares
@ $7.91, valued at
$395.5k
|
|
| 05/12/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 15,048 shares
@ $8.34, valued at
$125.5k
|
|
| 05/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/21/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 3,877 shares
@ $10.94, valued at
$42.4k
|
|
| 03/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/22/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 3,877 shares
@ $10.93, valued at
$42.4k
|
|
| 01/27/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 21,976 shares
@ $0
Paid exercise price by delivering 9,219 shares
@ $11.88, valued at
$109.5k
|
|
| 01/19/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 3,877 shares
@ $10.93, valued at
$42.4k
|
|
| 01/12/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Paid exercise price by delivering 32,190 shares
@ $11.26, valued at
$362.5k
|
|
| 01/09/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 5,651 shares
@ $0
Granted 9,343 options to buy
@ $11.06, valued at
$103.3k
|
|
| 11/16/2022 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 7,000 shares
@ $13.69, valued at
$95.8k
Sold 5,103 shares
@ $14.06, valued at
$71.7k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |